Chikungunya virus (CHIKV) is a mosquito-borne alphavirus causing fever, severe joint pain, rash, and muscle aches, mainly transmitted by Aedes mosquitoes. The outbreak began on islands in the Indian Ocean and had spread to 119 countries by 2025, including temperate regions such as France. Key control strategies include vector control, surveillance, health system preparedness, and international cooperation. Sino Biological supports research by providing recombinant CHIKV antigens and antibodies, which are useful for vaccines, antiviral drugs, and diagnostics.
Lilly’s weight loss pill orforglipron meets primary Phase III endpoint
Latest NewsEli Lilly, the US market leader in the lucrative diabetes and obesity space, is now challenging its competitor Novo Nordisk in the area of oral GLP-1 receptor agonists. Lilly’s orforglipron has met the primary endpoint of its registration study and is set to be submitted for approval in the United States.
Calluna Pharma starts efficacy test with unique IPF antibody
Latest NewsNorway-based Calluna Pharma A/S has initiated patient recruitment in late August for its Phase II AURORA trial investigating safety and efficacy of CAL101, a monoclonal antibody with unique mode of action to cure idiopathic pulmonary fibrosis.
Novartis secures US$30m+ licence option from BioArctic
Latest NewsFollowing the commercial launch of BioArctic AB’s Alzheimer’s antibody lecanemab, the Swedish company has announced a new deal: it will receive an upfront payment of US$30m, granting the Swiss company access to BioArctic’s BrainTransporter platform to transport therapeutics for neurodegeneration across the blood-brain barrier
Alzheimer’s antibody Lecanemab launched in the EU
Latest NewsSwedish BioArctic AB’s partner Eisai Pharma has started the European roll-out of their Alzheimer’s antibody lecanemab in Austria that will be followed by the German launch on September 1, 2025.
About POWTECH TECHNOPHARM
slider, Sponsored Publications, VideosPOWTECH TECHNOPHARM (Nuremberg, 23-25 September 2025) is the international trade fair for process engineering experts and a tailor-made technology platform for the pharmaceutical and life science industries.
US and EU confirm tariff deal on pharmaceuticals, generics largely exempt
Latest NewsThe US and EU have confirmed a trade agreement involving US import tariffs of 15% on prescription medicines. Generics manufacturers will face a maximum tariff of 2.5%.
New Head of Development
AppointmentsSwedish AlzeCure Pharma AB recently appointed Cecilia Wadell as Head of Development. She joins also the management team.
Mallia Aesthetics is about to launch MAL-838
Latest NewsGermany’s Mallia Aesthetics GmbH has announced the achievement of key regulatory milestones in preparation for the market launch of its sCD83-based hair growth stimulant, MAL-838, later this year.
2025 Chikungunya Outbreak: A Global Health Challenge
Sponsored PublicationsChikungunya virus (CHIKV) is a mosquito-borne alphavirus causing fever, severe joint pain, rash, and muscle aches, mainly transmitted by Aedes mosquitoes. The outbreak began on islands in the Indian Ocean and had spread to 119 countries by 2025, including temperate regions such as France. Key control strategies include vector control, surveillance, health system preparedness, and international cooperation. Sino Biological supports research by providing recombinant CHIKV antigens and antibodies, which are useful for vaccines, antiviral drugs, and diagnostics.
BioMed X and Novo Nordisk collaborate to optimise oral peptide therapeutics
Latest NewsNovo Nordisk has entered a collaboration with research institute BioMed X in an effort to regain market position lost to leading competitors in diabetes and obesity treatment. The partnership is focused on improving the low bioavailability of orally administered peptide-based medicines.